首页> 美国卫生研究院文献>other >The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes
【2h】

The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes

机译:间充质基质细胞(MSC)制造中冻结步骤的利用:对质量和细胞功能属性的潜在影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Some recent reports suggest that cryopreserved and thawed mesenchymal stromal cells (MSCs) may have impaired functional properties as compared to freshly harvested MSCs from continuous cultures. A cryopreservation step in the manufacturing process brings important benefits, since it enables immediate off-the-shelf access to the products and a completion of all quality testing before batch release and administration to the patient. Cryopreservation is also inevitable in MSC banking strategies. In this study, we present the results from the MSC stability testing program of our in-house manufactured clinical-grade allogeneic bone marrow-derived MSC product that is expanded in platelet lysate and frozen in passage 2. The current manufacturing protocol contains only one freezing step and the frozen MSC product is thawed bed-side at the clinic. We can conclude superior viability and cell recovery of the frozen and thawed MSC product utilizing the validated freezing and thawing protocols we have developed. The MSC phenotype and differentiation potential was generally found to be unaltered after thawing, but the thawed cells exhibited a 50% reduced, but not completely abolished, performance in an in vitro immunosuppression assay. The in vitro immunosuppression assay results should, however, be interpreted with caution, since the chosen assay mainly measures one specific immunosuppressive mechanism of MSCs to suppress T-cell proliferation. Since at least two freezing steps are usually necessary in MSC banking strategies, we went on to investigate the impact of repeated freezing on MSC quality attributes. We can conclude that two freezing steps with a preceding cell culture phase of at least one passage before freezing is feasible and does not substantially affect basic cell manufacturing parameters or quality attributes of the final frozen and thawed product. Our results suggest, however, that an exhaustive number of freezing steps (≥4) may induce earlier senescence. In conclusion, our results support the utilization of frozen MSC products and MSC banking strategies, but emphasize the need of always performing detailed studies on also the cryopreserved MSC counterpart and to carefully report the cryopreservation and thawing protocols.
机译:最近的一些报告表明,与从连续培养中新鲜收获的MSC相比,冷冻保存和融化的间充质基质细胞(MSC)可能具有受损的功能特性。制造过程中的低温保存步骤带来了重要的好处,因为它可以立即对产品进行现成的访问,并且可以在批量释放和施用于患者之前完成所有质量测试。在MSC银行策略中,冷冻保存也是不可避免的。在这项研究中,我们介绍了我们内部制造的临床级同种异体骨髓来源的MSC产品的MSC稳定性测试程序的结果,该产品在血小板裂解物中扩增并在第2代中冷冻。当前的生产方案仅包含一种冷冻步骤,将冷冻的MSC产品在诊所的床旁解冻。我们可以利用我们已经开发的经过验证的冷冻和解冻方案,得出冷冻和解冻的MSC产品优异的生存力和细胞回收率的结论。解冻后,通常发现MSC表型和分化潜能没有改变,但是在体外免疫抑制试验中,解冻的细胞表现出降低了50%的性能,但并未完全消除。但是,体外免疫抑制试验的结果应谨慎解释,因为所选的试验主要是测量MSC抑制T细胞增殖的一种特定免疫抑制机制。由于在MSC银行策略中通常至少需要两个冻结步骤,因此我们继续研究了重复冻结对MSC质量属性的影响。我们可以得出结论,在冷冻之前至少经过一个传代的先前细胞培养阶段的两个冷冻步骤是可行的,并且基本上不影响最终冷冻和解冻产品的基本细胞制造参数或质量属性。然而,我们的结果表明,彻底的冷冻步骤(≥4)可能会导致较早的衰老。总之,我们的结果支持冷冻MSC产品的利用和MSC银行策略,但强调需要始终对冷冻保存的MSC对应物进行详细研究,并仔细报告冷冻保存和解冻方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号